Carson Wealth (CWM LLC)
TLX

Carson Wealth (CWM LLC)’s Telix Pharmaceuticals TLX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6K Buy
+1,425
New +$10.9K ﹤0.01% 4643

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TLX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Telix Pharmaceuticals (TLX) in Q1 2026: 1,425 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #4643 among its holdings.

39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,425 shares of Telix Pharmaceuticals worth $13.6K as of Q1 2026.
  • Telix Pharmaceuticals was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4643 holding.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.